Article
20 Jan 2026
Red Light / Green Light: Navigating The Traffic Signals From The 44th Annual J.P. Morgan Healthcare Conference
AUTHORS CONTENT
Article
14 Jan 2026
OIG Analyzes Market Share Rebates And Bundled Discounts Under The Discount Safe Harbor
Article
05 Jan 2026
Federal Court Puts 340B Rebate Model On Hold
Article
15 Aug 2025
HRSA Unveils Pilot Program To Allow Limited 340B Drug Rebate Models
Article
30 Apr 2025
Arkansas Restricts PBM Ownership Of Pharmacies And Limits Manufacturers' Use Of Limited Distribution Networks
Article
23 Dec 2024
340B Drug Rebate Models: Status And Litigation Update
Article
28 May 2024
D.C. Circuit Becomes Second Federal Appeals Court To Allow Restrictions On 340B Contract Pharmacies
Article
20 May 2024
Key Takeaways From 2024 Asembia Specialty Pharmacy Summit
Article
02 May 2024
Healthcare Trends & Transactions Q1 2024
Article
14 Feb 2024
CMS & HHS Withdraw Appeal To Recent Copay Accumulator Federal District Court Decision: 2020 Accumulator Rule Still In Effect
Article
16 Jan 2024
Pushing A Balloon Into Or Against The Jet Stream? Key Takeaways From The J.P. Morgan Healthcare Conference
Article
08 Nov 2023
Court Guts 340B Program "Patient" Definition, Opening Door To More 340B Use
Article
21 Sep 2023
Alaska Board Of Pharmacy Issues Notice Altering The Notification Of Facility Changes
Article
01 Sep 2023
CMS Announces 10 Drugs Selected For Medicare Negotiation In 2026
Article
27 Jan 2021
Key Takeaways From Bass, Berry & Sims Connect During The Annual J.P. Morgan Healthcare Conference